在喘的效应阶段中,C3a过敏毒素受体的作用
A A Humbles1, B Lu, C A Nilsson
1Ina Sue Perlmutter Laboratory, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature
|September 13, 2000
概括
像C3a这样的补充性过敏毒素在喘发病过程中起作用. 阻止小鼠的C3a受体减少了过敏性气道疾病,这表明喘治疗的目标.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 具有天生的免疫力.
背景情况:
- 喘是一种慢性呼吸道炎症疾病,与阿托皮和IgE免疫有关.
- 喘的特征与补充性厌氧毒素C3a和C5a的作用一致.
- 补充激活对于对各种病原体的天生的防御至关重要.
研究的目的:
- 调查补充性厌氧毒素,特别是C3a在喘发病过程中的作用.
- 为了确定阻断C3a受体是否会影响过敏呼吸道疾病.
- 在暴露于过敏原后,评估人类喘患者的C3a水平.
主要方法:
- 利用过敏呼吸道疾病的小鼠模型.
- 在小鼠中遗传删除了C3a受体.
- 对小鼠进行过敏原挑战和评估肺生理学.
- 在肺内过敏原或盐酸沉积后,测量了人类喘患者的C3a水平.
主要成果:
- 基因删除C3a受体保护小鼠免受过敏原诱导的肺生理变化.
- 人类喘患者在肺内过敏原挑战后显示出显著的C3a生成.
- 在人类的盐水挑战后没有观察到显著的C3a增加.
结论:
- 天生的免疫系统,特别是补充成分C3a,与喘的发病有关.
- C3a受体对抗性可能代表喘的新疗法策略.
- 这项研究强调了天生的免疫力在喘中超越获得反应的参与.
相关概念视频
Allergic Reactions
26.4K
Overview
26.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Complement System
10.6K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40


